3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Terminated
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Lymphatic Metastasis
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
pembrolizumab
25
Paclitaxel
20
Carboplatin
17
Bevacizumab
12
Specimen Handling
10
Letrozole
10
abemaciclib
7
dostarlimab
6
Taxes
6
Fulvestrant
6
Megestrol Acetate
5
Medroxyprogesterone Acetate
5
Magnetic Resonance Spectroscopy
5
Drug Therapy
5
Doxorubicin
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
olaparib
4
lenvatinib
4
atezolizumab
4
Radiotherapy
4
Progestins
4
Observation
4
Nivolumab
4
Immunoglobulin G
4
Gemcitabine
4
trastuzumab deruxtecan
3
palbociclib
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Endometrial Neoplasms
×
Lymph Node Excision
×
Clear all
NCT03366051
2024-07-30
ALICE
AC Camargo Cancer Center
Phase NA
Recruiting
178 enrolled